← Eichor
Condition: Oropharyngeal Carcinoma Opc Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Oropharyngeal Carcinoma Opc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07209189Adaptive RadioTherapy for OroPharynx Cancer
Phase 2 · 2 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT04901234A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papil
Phase 2 · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT05307939Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)
Phase N/A · 2 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT06305676De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE)
NA · 1 location(s) · Royal North Shore Hospital · NCT06307015HPV-associated Oropharyngeal Carcinoma (HPV-OPC)
NA · 1 location(s) · Masaryk Memorial Cancer Institute · NCT07718620
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.